The Claim

In BALB/c mice, exposure to BDE-47 causes upregulation of the Cd36 protein, which plays a role in fatty acid transport, leading to increased hepatic fatty acid uptake and contributing to the development of steatosis.

Source: BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
6score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In these lab mice, a chemical called BDE-47 turns up a protein that pulls more fat into the liver, which can lead to fatty liver disease.

See the scientific wording

In BALB/c mice, BDE-47 exposure leads to upregulation of Cd36, a protein involved in fatty acid transport, which is associated with increased hepatic fatty acid uptake and contributes to the development of steatosis.

What the research says

1 study

  1. Study: BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice.

    The study shows that when mice are exposed to a chemical called BDE-47, a protein called Cd36 increases in the liver, causing more fat to be taken in and leading to fatty liver disease — just as the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.